5 Biotech Stocks That Delivered Big Gains - Key Catalysts Ahead For QURE, CDNA, ADPT, ELVN & AMLXrttnews·4 hours agoAMLX-2.12%ELVN+1.59%
Enliven Therapeutics, Inc. $ELVN is Seven Fleet Capital Management LP's 3rd Largest PositionMarket Beat·4 hours agoELVN+1.59%
Enliven Therapeutics, Inc. $ELVN is Avidity Partners Management LP's 6th Largest PositionMarket Beat·1 day ago, 02:40 AMELVN+1.59%
Enliven Therapeutics (NASDAQ:ELVN) CFO Sells 6,018 Shares of StockMarket Beat·Jul 28 at 11:08 AMELVN+1.59%STT+0.73%
Enliven Therapeutics CMO Helen Louise Collins disposes of USD 262,213 in common sharesPUBT·Jul 21 at 04:23 PMELVN+1.59%
The Goldman Sachs Group Issues Positive Forecast for Enliven Therapeutics (NASDAQ:ELVN) Stock PriceMarket Beat·Jul 21 at 07:48 AMELVN+1.59%IVZ+0.61%
Biotech Stocks At 52-Week Highs- CDNA, IART, AGL, BVS, ELVNrttnews·Jul 17 at 04:18 AMIART-2.75%BVS-8.00%
Enliven Therapeutics director Lori Anne Kunkel disposes of USD 504,256 common sharesPUBT·Jul 8 at 04:18 PMELVN+1.59%
OrbiMed Advisors reports Enliven Therapeutics common stock sale worth $38.02 millionPUBT·Jun 24 at 06:20 PMELVN+1.59%
Enliven Therapeutics CMO Helen Louise Collins disposes of USD 217,816 in common sharesPUBT·Jun 22 at 04:12 PMELVN+1.59%
OrbiMed Advisors reports $12.67 million Enliven Therapeutics common stock salePUBT·Jun 17 at 06:46 PMELVN+1.59%
Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares | ELVN Stock NewsStockTitan·Jun 15 at 07:40 AMELVN+1.59%GS-D+0.32%
